Introduction:

External Defibrillator Market was valued at US$ 3.8 billion in 2024 and is projected to grow at a CAGR of 9.8% to reach US$ 8.9 billion by 2034.

An external defibrillator is a small, lightweight electronic device through which an abnormally fast or irregular heartbeat can be stopped, and the heart's normal rhythm is restored by shock. When the heart stops beating suddenly, it is called sudden cardiac arrest. Death occurs soon if the treatment is not administered in less than a minute. Ventricular fibrillation is the most common cause of sudden cardiac arrest. The heart's lower chambers are the source of ventricular fibrillation, a fast and irregular heartbeat. Ventricular fibrillation, pulse-less ventricular tachycardia, and other potentially fatal cardiac dysrhythmias are frequently treated using external defibrillators.

Technological developments in external defibrillators are a crucial driver of the worldwide market for defibrillators. It includes the introduction of automated external defibrillators (AEDs) for general use, an increase in cases of sudden cardiac arrest, and a global increase in public knowledge of defibrillators. The American Heart Association released figures for 2022 that show that 6 million Americans, or 1.8% of the entire population, had heart failure in 2021. This indicates that heart failure is rather common in the nation. This is making it more critical than ever to be informed of technological advancements like wearable and automated defibrillators, which are anticipated to support the expansion of the external defibrillator market over the projected timeframe.

Furthermore, it is projected that increasing the appeal of healthcare would increase the sales of defibrillators for home use, such as automated and wearable external defibrillators. Shortly, demand for the external defibrillator market is anticipated to increase due to the defibrillator device's capacity to identify ventricular tachycardia and perform ventricular defibrillation at an early stage. Nevertheless, the worldwide market for external defibrillators benefited from technical developments due to cost-effectiveness, safety, clinical value, and high accessibility in the first treatment of sudden cardiac arrest.The target market's growth is anticipated to be hampered by safety concerns regarding automated external defibrillators and a lack of information regarding the availability of external defibrillators to avoid sudden cardiac arrest (SCA). Contrarily, one of the main things that might impede the industry's growth is product recalls and failures. Additionally, one of the main factors preventing the external defibrillator market from growing is faults in sensors or electrodes, such as poor skin contact or bad wiring, which can lead to erroneous readings or the inability to detect irregular cardiac rhythms.

 Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

External Defibrillator Market Key Drivers:

Rise in heart-related disorders

• The incidence of heart disorders has increased as a result of the rising number of cardiac patients brought about by the world's sedentary lifestyle and the aging population. As a result, hospital admissions have increased dramatically, especially in critical care units. According to the National Cancer Institute (NCI), the incidence of sudden cardiac arrest (SCA) increases with age, and middle-aged people (35–59 years old) account for a greater percentage (30–40%) of SCA cases. Defibrillator usage during a SCA incident is critical to minimizing complications and improving clinical outcomes. Therefore, the need for external defibrillators would be driven by the rising number of hospitalizations, the aging population, and the increasing frequency of cardiac diseases, particularly SCA instances. These factors would also contribute to the industry's growth.

Technological advancements

• Modern external defibrillators are more portable, easy to use, and require less maintenance due to technological improvements, which also boost their cost-effectiveness. The World Health Organization (WHO) states that manual external defibrillators' costs range from $1,000 to $25,000. Innovations in home-use personal AEDs, drone integration to improve response to cardiac arrests, AED tracking systems, and Internet of Things (IoT) and analytics usage are some of the noteworthy technological advances in the industry.

External Defibrillator Market Restraints:

Malfunctioning of the device                    

•  Wearable defibrillators commonly use sensors or electrodes to track the wearer's cardiac rhythm. Poor skin contact or defective wiring are two common malfunctions in these sensors and electrodes that can lead to false readings or the inability to identify irregular cardiac rhythms. The FDA was notified of many injuries and two fatalities. The goal of this defibrillator recall was to stop a possibly fatal malfunction. Hence, a product recall or an external defibrillator malfunction might have a detrimental effect on market demand.

Product failures

• Product recalls and failures are two main things that might prevent the industry from developing. A few manufacturing flaws allow moisture to get inside the external defibrillator, which increases the risk of a short circuit when the device shocks with high power. As a result, the patient may receive a lower-than-intended shock or none at all, and occasionally the device may stop responding to check-in requests and battery warnings. A product like this must be taken off the market since it causes major patient side effects.

External Defibrillator Market is segmented based on Product, End-User and region:

Product Insights:

• Manual External Defibrillator:

Medical professionals with training are required to use manual external defibrillators to interpret heart rhythms and administer electrical shocks as necessary. Hospitals and ambulances frequently have them because they provide exact control over therapy administration.

• Automated External:

When a medical emergency arises, automated external defibrillators (AEDs) can help non-medical individuals who are adequately trained to use them, such as flight attendants, police, fire department workers, security guards, and other lay rescuers.

• Semi-automated External Defibrillator:

Semi-automated external defibrillators need manual input from the user to deliver shocks to a patient by pressing a button after assessing their cardiac rhythm. Instead, they lead users through visual or auditory cues. Those with minimal first-aid training can use these defibrillators.

• Fully Automated Defibrillator:

Fully automated defibrillators are easier to operate since they identify the cardiac rhythm automatically and shock the patient without the need for user input.

• Wearable Cardioverter Defibrillator:

Patients who are in danger of abrupt cardiac arrest can wear wearable cardioverter defibrillators when they are not in a hospital. These gadgets keep a close eye on cardiac rhythms and will shock the user immediately if a potentially fatal arrhythmia is identified.

Among the segments mentioned above the one that dominated the market the most is the Automated External Defibrillator segment because of the growing popularity of these devices, advances in technology, and an increase in the number of cardiac arrests that occur outside of hospitals.

End-User Insights:

• Hospitals:

Hospitals are major consumers of external defibrillators, utilizing them in a variety of departments, including cardiac catheterization labs, intensive care units (ICUs), and emergency departments. For patients suffering from abrupt cardiac arrest or potentially fatal arrhythmias, these hospital critical care units must have rapid access to life-saving treatments.

• Public Access Market:

When an AED is placed in a public area, such an airport, a school, a sports stadium, or a workplace, bystanders may instantly aid someone experiencing a sudden cardiac arrest.

• Alternate Care Market:

This market field, includes clinics, ambulatory care facilities, and physician offices, and is crucial to the external defibrillator industry since it uses these devices mostly for diagnostic testing and outpatient treatments.

• Home:

People who are at risk of cardiac events are increasingly advised to use external defibrillators at home, particularly those who have a history of heart disease or known arrhythmias.

Among the segments mentioned above the one that dominated the market the most is the Hospitals segment because of the increasing number of patients visiting hospitals, new technology developments, and the infrastructure and highly qualified medical staff needed to carry out procedures in an emergency.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

External Defibrillator Market Regional Insights

• North America market is estimated to witness a significantly large revenue share over the forecast period, due to the existence of major companies, laws that encourage the availability of AEDs for public use, and the widespread use of external defibrillators in medical institutions
• Asia Pacific market finds lucrative market opportunities due to the growing elderly population, the rise in heart-related illnesses, and people's growing awareness of heart failures and cardiac arrests.
• Europe market is estimated to witness fastest revenue share due to its well-established healthcare system, sizable elderly population that is vulnerable to CVD adverse events, and the local presence of important corporations.
• Latin America market is increasing gradually as people become more aware of the risks associated with cardiovascular diseases and their preventive measures.
• Middle East & Africa market is an emerging market owing to the Because of the government's attempts to educate people about heart failure and cardiac arrests, as well as what to do in emergency circumstances.

Report Scope:

Attribute	Details
Market Size 2024	US$ 3.8 billion
Projected Market Size 2034	US$ 8.9 billion
CAGR Growth Rate	9.80%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product - Manual External Defibrillator, Automated External (Semi-automated External Defibrillator and Fully Automated Defibrillator) and Wearable Cardioverter Defibrillator, By End-User - Hospitals, Public Access Market, Alternate Care Market, and Home.
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the External Defibrillator Market report based on Product, End-User and region:

External Defibrillator Market, By Product:

• Manual External Defibrillator
• Automated External
  • Semi-automated External Defibrillator
  • Fully Automated Defibrillator
• Wearable Cardioverter Defibrillator

External Defibrillator Market, By End-User:

• Hospitals
• Public Access Market
• Alternate Care Market
• Home

External Defibrillator Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the External Defibrillator Market includes, Nihon Kohden Corporation, Cardiac Science Corporation, Philips Healthcare, HeartSine Technologies LLC., ZOLL Medical Corporation, Mindray Medical International Limited, Defibtech LLC, Physio-Control, Inc., GE Healthcare, and Schiller Ag.

Recent Development:

• In June 2020, Philips declared that the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company's HeartStart FR3 & HeartStart FRx automated external defibrillators (AEDs). This medication is an AED designed to treat pulseless ventricular tachycardias (VTs) and ventricular fibrillation (VF). The company strengthened its AED range and improved the lives of many victims of sudden cardiac arrest thanks to this regulatory approval.

• Nihon Kohden Corporation*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cardiac Science Corporation
• Philips Healthcare
• HeartSine Technologies LLC.
• ZOLL Medical Corporation
• Mindray Medical International Limited
• Defibtech LLC
• Physio-Control, Inc.
• GE Healthcare
• Schiller Ag

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for medical carts Strategies
     • Key Questions this Study will Answer
     • Market Snippet,  By Product
     • Market Snippet, By End-User
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restrains
     • Market Opportunities
     • Market Trends
   • DR Impact Analysish
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Market Segmentation,  By Product, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Manual External Defibrillator
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Automated External (Semi-automated External Defibrillator and Fully Automated Defibrillator)
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Wearable Cardioverter Defibrillator
  • Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End-User, Forecast Period up to 10 Years, (US$ Bn)

Overview

• Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
• Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
• Segment Trends
• Hospitals
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Public Access Market
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Alternate Care Market
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Home
  • Buildings Overview
  • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Globak Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

• Overview
  • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (US$ Bn),  By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-User, Forecast Period up to 10 Years

• Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • U.S.
  • Canada
• Europe
  • Market Size and Forecast (US$ Bn),  By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • UK
    • France
    • Germany
    • Russia
    • Italy
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast (US$ Bn),  By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast (US$ Bn),  By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast (US$ Bn),  By Product, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
• GCC
• Israel
• South Africa
• Rest of Middle East

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
2. Company Profiles 

• Nihon Kohden Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Cardiac Science Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Philips Healthcare
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• HeartSine Technologies LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• ZOLL Medical Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Mindray Medical International Limited
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

The Last Word

• Future Impact
• About Us
• Contact